According to Blueprint Medicines
's latest financial reports the company has a price-to-book ratio of 13.4213.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 19.3 | -55.07% |
2023-12-31 | 42.9 | 742.97% |
2022-12-31 | 5.09 | -21.55% |
2021-12-31 | 6.49 | 52.7% |
2020-12-31 | 4.25 | -49.98% |
2019-12-31 | 8.50 | 50.03% |
2018-12-31 | 5.67 | 7.87% |
2017-12-31 | 5.25 | 20.63% |
2016-12-31 | 4.35 | -12.06% |
2015-12-31 | 4.95 | |
2014-12-31 | N/A |